Aetnas commercial health insurance plans are more likely to cover Wegovy than its government-sponsored plans, though there are exceptions
Yes, its therapeutic action can be slower than considering the injectable
They are separate medications requiring separate charts, separate math, and separate conversations with your provider
A typical flow for a patient entering this market with any digital health company looks something like this: Considering this, founders or companies that are looking to expand into this sector technically they need the following: Prescribing & Intake: The most efficient peptide platforms use an asynchronous "store-and-forward" model
You're reintroducing the peptide to an environment where it can fold, move, and, unfortunately, break down